Pericoronary Adipocyte Size Gradient
Recruiting
Observational Study
Heart Failure
Heart Transplantation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 30 – 90
- Sex
- Any
- Study type
- Observational
- Participants needed
- 60 (estimated)
- Sponsor
- Institute for Clinical and Experimental Medicine · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Evaluation of pericoronary adipocyte gradient (PCAT) in relationship with local atherosclerotic changes in a patient undergoing heart transplantation.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 30-90 years
* Diagnosis of dilatational or ischemic cardiomyopathy
* Patients undergoing heart transplantation in IKEM
Exclusion Criteria:
* Known combined diagnosis of dilatational and ischemic cardiomyopathy
* Arrhythmogenic cardiomyopathy
* Congenital heart defects
* …
Contacts